These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30362546)

  • 1. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
    J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
    Jiang J; Piao X; Hu S; Gao J; Bao M
    Aging (Albany NY); 2020 May; 12(10):8820-8836. PubMed ID: 32434961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
    Dong Y; Han LL; Xu ZX
    Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-128 Protects Dopamine Neurons from Apoptosis and Upregulates the Expression of Excitatory Amino Acid Transporter 4 in Parkinson's Disease by Binding to AXIN1.
    Zhou L; Yang L; Li YJ; Mei R; Yu HL; Gong Y; Du MY; Wang F
    Cell Physiol Biochem; 2018; 51(5):2275-2289. PubMed ID: 30537735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson's Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway.
    Zhang Y; Xu W; Nan S; Chang M; Fan J
    J Mol Neurosci; 2019 Oct; 69(2):197-214. PubMed ID: 31270675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
    Liu YY; Zhang YN; Yang QS
    J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF-1α/microRNA-128-3p axis protects hippocampal neurons from apoptosis via the
    Zhang G; Chen L; Liu J; Jin Y; Lin Z; Du S; Fu Z; Chen T; Qin Y; Sui F; Jiang Y
    Aging (Albany NY); 2020 Mar; 12(5):4067-4081. PubMed ID: 32167488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease.
    Wu X; Meng X; Tan F; Jiao Z; Zhang X; Tong H; He X; Luo X; Xu P; Qu S
    ACS Chem Neurosci; 2019 Mar; 10(3):1791-1800. PubMed ID: 30676715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
    Tao X; Zhang W; Chen C; Tao Y; Tao Y; Chen Z; Zhang G
    Aging (Albany NY); 2024 May; 16(10):8732-8746. PubMed ID: 38775730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-542-5p protects against acute lung injury in mice with severe acute pancreatitis by suppressing the mitogen-activated protein kinase signaling pathway through the negative regulation of P21-activated kinase 1.
    Wu XM; Ji KQ; Wang HY; Zhao Y; Jia J; Gao XP; Zang B
    J Cell Biochem; 2019 Jan; 120(1):290-304. PubMed ID: 30216510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
    Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
    Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
    J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity.
    Pajarillo E; Johnson J; Rizor A; Nyarko-Danquah I; Adinew G; Bornhorst J; Stiboller M; Schwerdtle T; Son DS; Aschner M; Lee E
    J Biol Chem; 2020 Nov; 295(46):15662-15676. PubMed ID: 32893191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the RUNX3-miR-186-3p-DAT-IGF1R axis as a therapeutic strategy in a Parkinson's disease model.
    Huang P; Wan Z; Qu S
    J Transl Med; 2024 Aug; 22(1):719. PubMed ID: 39103832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease.
    Zhao XH; Wang YB; Yang J; Liu HQ; Wang LL
    J Cell Biochem; 2019 Sep; 120(9):14995-15006. PubMed ID: 31135066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy.
    Dong H; Yan J; Huang P; Wang X; Zhang R; Zhang C; Wang W; Qian W; Zhou J; Zhao Y; Gao J; Zhang M; Ma X; Wang Z; Yi C; Zhang J; Chen W
    Biomed Pharmacother; 2024 Feb; 171():116123. PubMed ID: 38211424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons.
    Kim H; Oh JY; Choi SL; Nam YJ; Jo A; Kwon A; Shin EY; Kim EG; Kim HK
    Mol Brain; 2016 Apr; 9(1):45. PubMed ID: 27121078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.
    Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
    Neuropharmacology; 2019 Dec; 161():107559. PubMed ID: 30851309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid attenuates manganese-induced reduction in expression of GLT-1 and GLAST with concomitant changes in murine dopaminergic neurotoxicity.
    Johnson J; Pajarillo E; Karki P; Kim J; Son DS; Aschner M; Lee E
    Neurotoxicology; 2018 Jul; 67():112-120. PubMed ID: 29778792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.